MedTrace Logo

Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers

NCT05113472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1291

Last updated 2021-11-09

No results posted yet for this study

Summary

Limited large-scale studies have been conducted to investigate the adverse effects of COVID-19 vaccine in Latin America, particularly among the healthcare worker (HCW) population in Ecuador. The objective of this study was to assess a cohort of Ecuadorian healthcare workers for adverse reactions following vaccination with the Pfizer-BioNTech vaccine.

Conditions

  • Adverse Drug Event

Interventions

BIOLOGICAL

Pfizer-BioNTech COVID-19 vaccine

Patients who were administered any dose of the Pfizer-BioNTech COVID-19 vaccine.

Sponsors & Collaborators

  • Respiralab

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • Ecuador

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05113472 on ClinicalTrials.gov